Figures & data
Table 1 Clinical characteristics of all 223 participants in the study
Figure 1 Agarose electrophoresis result of the ARMS2 A69S PCR-RFLP genotyping method.
Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; MW, molecular weight.
![Figure 1 Agarose electrophoresis result of the ARMS2 A69S PCR-RFLP genotyping method.](/cms/asset/7894d3f3-35d3-471f-9f22-5b362fe7b448/doph_a_134538_f0001_c.jpg)
Figure 2 Agarose electrophoresis result of the CD14 C260T PCR-RFLP genotyping method.
Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.
![Figure 2 Agarose electrophoresis result of the CD14 C260T PCR-RFLP genotyping method.](/cms/asset/5db444c4-26bc-496e-adcd-4139027b987a/doph_a_134538_f0002_b.jpg)
Figure 3 Agarose electrophoresis result of the TLR4 Asp299Gly PCR-RFLP genotyping method.
Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.
![Figure 3 Agarose electrophoresis result of the TLR4 Asp299Gly PCR-RFLP genotyping method.](/cms/asset/b395ffe3-9f56-41a3-a800-7411b2de9104/doph_a_134538_f0003_c.jpg)
Figure 4 Agarose electrophoresis result of the TLR4 Thr399Ile PCR-RFLP genotyping method.
Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; MW, molecular weight.
![Figure 4 Agarose electrophoresis result of the TLR4 Thr399Ile PCR-RFLP genotyping method.](/cms/asset/0f86e907-5ea7-4c3f-9d57-da23c24c12c9/doph_a_134538_f0004_b.jpg)
Table 2 Genotype frequencies, inheritance models, and calculated ORs for the A69S SNP in the ARMS2 gene (G wild-type allele, T risk mutant allele)
Table 3 Genotype frequencies, inheritance models, and calculated ORs for the C260T SNP in the CD14 gene (C wild-type allele, T mutant allele)
Table 4 Genotype frequencies and calculated ORs for the Asp299Gly (A wild-type allele, G risk mutant allele) and the Thr399Ile (C wild-type allele, T risk mutant allele) SNPs in the TLR4 gene
Table 5 TLR4 gene haplotype association with the disease
Table 6 Multivariate model of AMD risk based on genotypes and clinical and environmental factors
Figure S1 DNA sequencing analysis of a wild-type GG, a heterozygote G/T, and a mutant TT around the ARMS2 A69S SNP area (forward primer).
Abbreviation: SNP, single-nucleotide polymorphism.
![Figure S1 DNA sequencing analysis of a wild-type GG, a heterozygote G/T, and a mutant TT around the ARMS2 A69S SNP area (forward primer).Abbreviation: SNP, single-nucleotide polymorphism.](/cms/asset/6844ab5f-fcca-40fb-a619-3f99cefa2230/doph_a_134538_sf0001_c.jpg)
Figure S2 DNA sequencing analysis of a wild-type GG, a heterozygote G/T, and a mutant TT around the CD14 C260T SNP area (reverse primer).
Abbreviation: SNP, single-nucleotide polymorphism.
![Figure S2 DNA sequencing analysis of a wild-type GG, a heterozygote G/T, and a mutant TT around the CD14 C260T SNP area (reverse primer).Abbreviation: SNP, single-nucleotide polymorphism.](/cms/asset/754bf8b0-7858-4ea5-9b05-a6422f0bebaf/doph_a_134538_sf0002_c.jpg)
Figure S3 DNA sequencing analysis of a wild-type AA and a heterozygote A/G around the TLR4 Asp299Gly SNP area (forward primer).
Abbreviation: SNP, single-nucleotide polymorphism.
![Figure S3 DNA sequencing analysis of a wild-type AA and a heterozygote A/G around the TLR4 Asp299Gly SNP area (forward primer).Abbreviation: SNP, single-nucleotide polymorphism.](/cms/asset/c1a5735c-577c-47eb-9444-0b6a63df94f2/doph_a_134538_sf0003_c.jpg)
Table S1 Sequences of primers used in PCR-RFLP genotyping methods of SNPs in ARMS2, CD14, and TLR4 genes
Table S2 Multivariate model of AMD risk with all SNPs and all clinical variables